Accelerate to discover

Homepage>Discover>Assessment of pro-arrhythmic effects using xCELLigence Cardio system and Pluricyte Cardiomyocytes

Dec 28, 2020

Radio-active sources have been used routinely for the preconditioning in humanized mouse models, but safety issues have...

EV imaging series: Using ONI super-resolution to characterize single-EVs

Dec 23, 2020

To date, researchers commonly use flow-based characterization methods, fluorescence imaging techniques and electron...

Don’t Let Waste Anesthetic Gases Harm You!

Dec 21, 2020

Many projects have been devoted to the study of the correlation between anesthetics and Alzheimer’s disease....

Coming in spring 2021, meet the Cytek Aurora CS

Dec 16, 2020

Ever wanted to take your full spectrum panel from your Cytek Aurora or Northern Lights cytometer and sort? Soon, you...

Dec 30, 2020

Advances in Leukemia research using shear flow and Bioflux system

Dec 10, 2020

Leukemia is a rare cancer with many subtypes. The production of abnormal leukocytes create disruptions in the immune...

Do you have our CellRad benchtop irradiator? It’s the only one on the market!

Dec 8, 2020

The CellRad is a smaller, simpler, safer, and more cost effective alternative to radioisotope or high-powered X-ray...

Dosimetric characterization of an X-ray irradiator for use with cells

Dec 4, 2020

This study aims to characterize an X-ray irradiator for use with cells using its internal parallel-plate ionization...

Dec 30, 2020

Modeling multiple myeloma-Bone Marrow interactions using Synthecon rotating-wall vessels

Dec 2, 2020

Multiple myeloma develops primarily inside the bone marrow microenvironment, that confers pro-survival signals and drug...

Show all topics (10)

Assessment of pro-arrhythmic effects using xCELLigence Cardio system and Pluricyte Cardiomyocytes

Aug 21, 2019

This application note describes our recommendations for the analysis of Pluricyte Cardiomyocytes electrophysiology by MEA and impedance measurements using the xCELLigence RTCA Cardio ECR system (ACEA Biosciences). In addition, a case study describing the assessment of the effects of a set of pro-arrhythmic compounds in Pluricyte Cardiomyocytes, showing the expected pharmacological responses, is provided in this document. Cardiomyocytes, cultured in Pluricyte Cardiomyocyte Medium, in combination with the xCELLigence RTCA CardioECRsystem provide a highly relevant in vitro assay platform to study the cardiac safety profile of compounds during drug development.